Syngene International Ltd (SYNGENE)

Company profile

Sector

Healthcare Research, Analytics & Technology

Industry

Healthcare Services

Market cap (₹ Cr)

16,748.23

Syngene International Ltd. operates as a global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries. The company is headquartered in Bangalore, Karnataka and currently employs 6,847 full-time employees. The company went IPO on 2015-08-11. The firm is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation, and analytical development, along with clinical development services. The company offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects. SynVent's portfolio covers modalities and therapeutic areas ranging from small molecule inhibitors to targeted protein stabilization. The company serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 372.5

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

47.39

52-week high

678.95

52-week low

344.45

Revenue CAGR, 3 years (%)

5.4

Revenue CAGR, 5 years (%)

11.35

EPS CAGR, 3 years (%)

-12.09

EPS CAGR, 5 years (%)

-4.93

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

52.68%

FII

13.9%

DII

26.44%

Public

6.69%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• Indegene Ltd₹ 12,288.67 Cr

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Syngene International Ltd do?

Syngene International Ltd. operates as a global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries. The company is headquartered in Bangalore, Karnataka and currently employs 6,847 full-time employees. The company went IPO on 2015-08-11. The firm is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation, and analytical development, along with clinical development services. The company offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects. SynVent's portfolio covers modalities and therapeutic areas ranging from small molecule inhibitors to targeted protein stabilization. The company serves the pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.

Which sector is Syngene International Ltd in?

Syngene International Ltd is in the Healthcare Research, Analytics & Technology sector, Healthcare Services industry.

What are Syngene International Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 3738.70 Cr, profit after tax 316.70 Cr.

What is the promoter holding and pledge in Syngene International Ltd?

Promoter holding is 52.68%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to Syngene International Ltd?

Companies in the same sector of similar size: Indegene Ltd.